trending Market Intelligence /marketintelligence/en/news-insights/trending/_ijgNv-ixH2JQT-fmRJVvA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

CanniMed receives Health Canada's approval to produce medical cannabis capsules

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


CanniMed receives Health Canada's approval to produce medical cannabis capsules

Health Canada granted CanniMed Therapeutics Inc. license to produce medical cannabis capsules.

The company has initiated production of its CanniMed capsules following receipt of the production license.